WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

Kodu・Aktsiate loetelu・Beauty Health Co

Beauty Health Co

Suletud

1.52 -2.56

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.5

Max

1.52

Põhinäitajad
By Trading Economics
Sissetulek	-31M -11M
Müük	-7.5M 71M
Kasumimarginaal	-15.612
Töötajad	769
EBITDA	-24M 4.1M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+33.99% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	11. märts 2026

Turustatistika
By TradingEconomics
Turukapital	18M 191M
Eelmine avamishind	4.08
Eelmine sulgemishind	1.52

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

1.05 / 1.42 Toetus ja vastupanu

Beauty Health Co Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. jaan 2026, 23:49 UTC

Market Talk

Oil Falls on Possible Technical Correction -- Market Talk

25. jaan 2026, 23:43 UTC

Market Talk

Correction to Gold Rises Above $5000/oz Market Talk

25. jaan 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. jaan 2026, 23:43 UTC

Market Talk

Nikkei May Fall After Yen's Sharp Rebound -- Market Talk

25. jaan 2026, 23:36 UTC

Market Talk

Gold Rises Above $5,000/oz for First Time Amid Geopolitical Tensions -- Market Talk

25. jaan 2026, 19:30 UTC

Omandamised, ülevõtmised, äriostud

Merck No Longer in Talks to Acquire Revolution Medicines, Sources Say -- WSJ

25. jaan 2026, 19:30 UTC

Omandamised, ülevõtmised, äriostud

Companies Had Been Discussing Roughly $30B Deal -- WSJ

25. jaan 2026, 19:30 UTC

Omandamised, ülevõtmised, äriostud

Merck No Longer in Talks to Buy Revolution Medicines -- WSJ

24. jaan 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

24. jaan 2026, 09:20 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

24. jaan 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. jaan 2026, 09:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

24. jaan 2026, 06:18 UTC

Omandamised, ülevõtmised, äriostud

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23. jaan 2026, 22:30 UTC

Market Talk

Global Equities Roundup: Market Talk

23. jaan 2026, 22:30 UTC

Market Talk

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23. jaan 2026, 22:03 UTC

Tulu

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23. jaan 2026, 21:52 UTC

Tulu

Omandamised, ülevõtmised, äriostud

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23. jaan 2026, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

23. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23. jaan 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

23. jaan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23. jaan 2026, 21:39 UTC

Tulu

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23. jaan 2026, 21:15 UTC

Omandamised, ülevõtmised, äriostud

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23. jaan 2026, 21:12 UTC

Tulu

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23. jaan 2026, 20:31 UTC

Tulu

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23. jaan 2026, 20:12 UTC

Market Talk

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23. jaan 2026, 20:07 UTC

Market Talk

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23. jaan 2026, 19:36 UTC

Market Talk

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23. jaan 2026, 19:30 UTC

Market Talk

Tulu

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23. jaan 2026, 19:18 UTC

Market Talk

Gold and Silver Step Up to More Records -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Beauty Health Co Prognoos

Hinnasiht

By TipRanks

33.99% tõus

12 kuu keskmine prognoos

Keskmine 2.05 USD 33.99%

Kõrge 3.5 USD

Madal 1.5 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Beauty Health Co 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Beauty Health Co aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

1.05 / 1.42Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Beauty Health Co

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.